Petrozza V, Porta R, Franchitto A, Leuzzi G, Correr S, Carpino F

Renal ischemia and pharmacological prevention: experimental structural and ultrastructural observations.

Ital J Anat Embryol 1994; 189-99.

Taglialatela A, Alvarez S, Leuzzi G, Sannino V, Ranjha L, Huang JW, Madubata C, Anand R, Levy B, Rabadan R, Cejka P, Costanzo V, Ciccia A

Restoration of Replication Fork Stability in BRCA1- and BRCA2-Deficient Cells by Inactivation of SNF2-Family Fork Remodelers.

Mol Cell 2017; 414-430.e8. doi: 10.1016/j.molcel.2017.09.036

Simonelli V, Leuzzi G, Basile G, D'Errico M, Fortini P, Franchitto A, Viti V, Brown AR, Parlanti E, Pascucci B, Palli D, Giuliani A, Palombo F, Sobol RW, Dogliotti E

Crosstalk between mismatch repair and base excision repair in human gastric cancer.

Oncotarget 2017; 84827-84840. doi: 10.18632/oncotarget.10185

Pascucci B, Fragale A, Marabitti V, Leuzzi G, Calcagnile AS, Parlanti E, Franchitto A, Dogliotti E, D'Errico M

CSA and CSB play a role in the response to DNA breaks.

Oncotarget 2018; 11581-11591. doi: 10.18632/oncotarget.24342

Billing D, Horiguchi M, Wu-Baer F, Taglialatela A, Leuzzi G, Nanez SA, Jiang W, Zha S, Szabolcs M, Lin CS, Ciccia A, Baer R

The BRCT Domains of the BRCA1 and BARD1 Tumor Suppressors Differentially Regulate Homology-Directed Repair and Stalled Fork Protection.

Mol Cell 2018; 127-139.e8. doi: 10.1016/j.molcel.2018.08.016

Nambiar TS, Billon P, Diedenhofen G, Hayward SB, Taglialatela A, Cai K, Huang JW, Leuzzi G, Cuella-Martin R, Palacios A, Gupta A, Egli D, Ciccia A

Stimulation of CRISPR-mediated homology-directed repair by an engineered RAD18 variant.

Nat Commun 2019; 3395. doi: 10.1038/s41467-019-11105-z

Huang JW, Acharya A, Taglialatela A, Nambiar TS, Cuella-Martin R, Leuzzi G, Hayward SB, Joseph SA, Brunette GJ, Anand R, Soni RK, Clark NL, Bernstein KA, Cejka P, Ciccia A

MCM8IP activates the MCM8-9 helicase to promote DNA synthesis and homologous recombination upon DNA damage.

Nat Commun 2020; 2948. doi: 10.1038/s41467-020-16718-3

Cuella-Martin R, Hayward SB, Fan X, Chen X, Huang JW, Taglialatela A, Leuzzi G, Zhao J, Rabadan R, Lu C, Shen Y, Ciccia A

Functional interrogation of DNA damage response variants with base editing screens.

Cell 2021; 1081-1097.e19. doi: 10.1016/j.cell.2021.01.041

Li Y, Goldberg EM, Chen X, Xu X, McGuire JT, Leuzzi G, Karagiannis D, Tate T, Farhangdoost N, Horth C, Dai E, Li Z, Zhang Z, Izar B, Que J, Ciccia A, Majewski J, Yoon AJ, Ailles L, Mendelsohn CL, Lu C

Histone methylation antagonism drives tumor immune evasion in squamous cell carcinomas.

Mol Cell 2022; 3901-3918.e7. doi: 10.1016/j.molcel.2022.09.007

Conte MI, Poli MC, Taglialatela A, Leuzzi G, Chinn IK, Salinas SA, Rey-Jurado E, Olivares N, Veramendi-Espinoza L, Ciccia A, Lupski JR, Aldave Becerra JC, Mace EM, Orange JS

Partial loss-of-function mutations in GINS4 lead to NK cell deficiency with neutropenia.

JCI Insight 2022; . doi: 10.1172/jci.insight.154948

Klapp V, Álvarez-Abril B, Leuzzi G, Kroemer G, Ciccia A, Galluzzi L

The DNA Damage Response and Inflammation in Cancer.

Cancer Discov 2023; 1521-1545. doi: 10.1158/2159-8290.CD-22-1220

Walsh ZH, Shah P, Kothapalli N, Shah SB, Nikolenyi G, Brodtman DZ, Leuzzi G, Rogava M, Mu M, Ho P, Abuzaid S, Vasan N, AlQuraishi M, Milner JD, Ciccia A, Melms JC, Izar B

Mapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens.

Nat Biotechnol 2025; 384-395. doi: 10.1038/s41587-024-02235-x

Gu J, Iyer A, Wesley B, Taglialatela A, Leuzzi G, Hangai S, Decker A, Gu R, Klickstein N, Shuai Y, Jankovic K, Parker-Burns L, Jin Y, Zhang JY, Hong J, Niu X, Costa JA, Pezet MG, Chou J, Chen C', Paiva M, Snoeck HW, Landau DA, Azizi E, Chan EM, Ciccia A, Gaublomme JT

Mapping multimodal phenotypes to perturbations in cells and tissue with CRISPRmap.

Nat Biotechnol 2025; 1101-1115. doi: 10.1038/s41587-024-02386-x

Masud W, Russo L, Chapdelaine-Trépanier V, Hayward SB, He W, Cirò M, Mercurio C, Xu H, Ciccia A, Cuella-Martin R, Leuzzi G

A base editing resource for functional annotation of DNA repair variants in breast-derived cell models.

Front Cell Dev Biol 2026; 1714494. doi: 10.3389/fcell.2026.1714494

Petta S, Cammà C, Scazzone C, Tripodo C, Di Marco V, Bono A, Cabibi D, Licata G, Porcasi R, Marchesini G, Craxí A

Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C.

Hepatology 2010; 1158-67. doi: 10.1002/hep.23489

Di Bernardo A, Macor P, Guarnotta C, Franco G, Florena AM, Tedesco F, Tripodo C

Humoral immunotherapy of multiple myeloma: perspectives and perplexities.

Expert Opin Biol Ther 2010; 863-73. doi: 10.1517/14712591003774063

Maffei R, Martinelli S, Santachiara R, Rossi D, Guarnotta C, Sozzi E, Zucchetto A, Rigolin GM, Fiorcari S, Castelli I, Fontana M, Coluccio V, Leonardi G, Zucchini P, Tripodo C, Cuneo A, Gattei V, Del Poeta G, Forconi F, Gaidano G, Torelli G, Marasca R

Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia.

Blood 2010; 584-92. doi: 10.1182/blood-2009-11-252494

Tripodo C, Gri G, Piccaluga PP, Frossi B, Guarnotta C, Piconese S, Franco G, Vetri V, Pucillo CE, Florena AM, Colombo MP, Pileri SA

Mast cells and Th17 cells contribute to the lymphoma-associated pro-inflammatory microenvironment of angioimmunoblastic T-cell lymphoma.

Am J Pathol 2010; 792-802. doi: 10.2353/ajpath.2010.091286

Piconese S, Pittoni P, Burocchi A, Gorzanelli A, Carè A, Tripodo C, Colombo MP

A non-redundant role for OX40 in the competitive fitness of Treg in response to IL-2.

Eur J Immunol 2010; 2902-13. doi: 10.1002/eji.201040505

Agostinis C, Bulla R, Tripodo C, Gismondi A, Stabile H, Bossi F, Guarnotta C, Garlanda C, De Seta F, Spessotto P, Santoni A, Ghebrehiwet B, Girardi G, Tedesco F

An alternative role of C1q in cell migration and tissue remodeling: contribution to trophoblast invasion and placental development.

J Immunol 2010; 4420-9. doi: 10.4049/jimmunol.0903215

Marín GH, Mansilla E, Mezzaroba N, Zorzet S, Núñez L, Larsen G, Tau JM, Maceira A, Spretz R, Mertz C, Ingrao S, Tripodo C, Tedesco F, Macor P

Exploratory study on the effects of biodegradable nanoparticles with drugs on malignant B cells and on a human/mouse model of Burkitt lymphoma.

Curr Clin Pharmacol 2010; 246-50. doi: 10.2174/157488410793352058

Rinaldi A, Mian M, Chigrinova E, Arcaini L, Bhagat G, Novak U, Rancoita PM, De Campos CP, Forconi F, Gascoyne RD, Facchetti F, Ponzoni M, Govi S, Ferreri AJ, Mollejo M, Piris MA, Baldini L, Soulier J, Thieblemont C, Canzonieri V, Gattei V, Marasca R, Franceschetti S, Gaidano G, Tucci A, Uccella S, Tibiletti MG, Dirnhofer S, Tripodo C, Doglioni C, Dalla Favera R, Cavalli F, Zucca E, Kwee I, Bertoni F

Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome.

Blood 2011; 1595-604. doi: 10.1182/blood-2010-01-264275

Rasi S, Spina V, Bruscaggin A, Vaisitti T, Tripodo C, Forconi F, De Paoli L, Fangazio M, Sozzi E, Cencini E, Laurenti L, Marasca R, Visco C, Xu-Monette ZY, Gattei V, Young KH, Malavasi F, Deaglio S, Gaidano G, Rossi D

A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome.

Br J Haematol 2011; 284-94. doi: 10.1111/j.1365-2141.2010.08482.x

Piccaluga PP, De Falco G, Kustagi M, Gazzola A, Agostinelli C, Tripodo C, Leucci E, Onnis A, Astolfi A, Sapienza MR, Bellan C, Lazzi S, Tumwine L, Mawanda M, Ogwang M, Calbi V, Formica S, Califano A, Pileri SA, Leoncini L

Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes.

Blood 2011; 3596-608. doi: 10.1182/blood-2010-08-301556

Piccaluga PP, Agostinelli C, Gazzola A, Tripodo C, Bacci F, Sabattini E, Sista MT, Mannu C, Sapienza MR, Rossi M, Laginestra MA, Sagramoso-Sacchetti CA, Righi S, Pileri SA

Pathobiology of hodgkin lymphoma.

Adv Hematol 2011; 920898. doi: 10.1155/2011/920898

Piconese S, Costanza M, Musio S, Tripodo C, Poliani PL, Gri G, Burocchi A, Pittoni P, Gorzanelli A, Colombo MP, Pedotti R

Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient Kit W-sh/W-sh mice.

Lab Invest 2011; 627-41. doi: 10.1038/labinvest.2011.3

Petta S, Tripodo C, Grimaudo S, Cabibi D, Cammà C, Di Cristina A, Di Marco V, Di Vita G, Ingrao S, Mazzola A, Marchesini G, Pipitone R, Craxì A

High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis.

Dig Liver Dis 2011; 404-10. doi: 10.1016/j.dld.2010.12.013

Tripodo C, Sangaletti S, Piccaluga PP, Prakash S, Franco G, Borrello I, Orazi A, Colombo MP, Pileri SA

The bone marrow stroma in hematological neoplasms--a guilty bystander.

Nat Rev Clin Oncol 2011; 456-66. doi: 10.1038/nrclinonc.2011.31

Ferretti E, Bertolotto M, Deaglio S, Tripodo C, Ribatti D, Audrito V, Blengio F, Matis S, Zupo S, Rossi D, Ottonello L, Gaidano G, Malavasi F, Pistoia V, Corcione A

A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment.

Leukemia 2011; 1268-77. doi: 10.1038/leu.2011.88

Piccaluga PP, Agostinelli C, Tripodo C, Gazzola A, Bacci F, Sabattini E, Pileri SA

Peripheral T-cell lymphoma classification: the matter of cellular derivation.

Expert Rev Hematol 2011; 415-25. doi: 10.1586/ehm.11.37

Zappasodi R, Bongarzone I, Ghedini GC, Castagnoli L, Cabras AD, Messina A, Tortoreto M, Tripodo C, Magni M, Carlo-Stella C, Gianni AM, Pupa SM, Di Nicola M

Serological identification of HSP105 as a novel non-Hodgkin lymphoma therapeutic target.

Blood 2011; 4421-30. doi: 10.1182/blood-2011-06-364570

Piconese S, Costanza M, Tripodo C, Sangaletti S, Musio S, Pittoni P, Poliani PL, Burocchi A, Passafaro AL, Gorzanelli A, Vitali C, Chiodoni C, Barnaba V, Pedotti R, Colombo MP

The matricellular protein SPARC supports follicular dendritic cell networking toward Th17 responses.

J Autoimmun 2011; 300-10. doi: 10.1016/j.jaut.2011.09.002

Morabito F, De Filippi R, Laurenti L, Zirlik K, Recchia AG, Gentile M, Morelli E, Vigna E, Gigliotti V, Calemma R, Amoroso B, Neri A, Cutrona G, Ferrarini M, Molica S, Del Poeta G, Tripodo C, Pinto A

The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia.

Blood 2011; 6353-61. doi: 10.1182/blood-2011-04-345587

%PLACEHOLDER%